AbbVie will buy Aliada Therapeutics for US$1.4 billion in cash, it said on Monday (Oct 28), gaining access to the privately ...

One in 20 of suffer from SAD. So, if the shorter days send your mood spiralling, here are the practical steps to boost your ...

Cyclothymia often goes unnoticed because it's less severe than bipolar disorder, but the decisions associated with it may ...

Ireland's first psychedelics conference at Trinity College highlights potential mental health benefits of hallucinogens.

AbbVie has entered a collaboration with Hungary-based pharmaceutical company Gedeon Richter to develop new treatments for ...

Researchers found that a 10-week course of home-based transcranial direct current stimulation (tDCS) significantly improved ...

For women with bipolar, menopause can bring extra challenges. Here’s what to know and how to manage both during this life ...

Alto Neuroscience’s depression treatment failed to beat placebo just nine months after the biotech went public. The stunning ...

Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study.

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the clearance of an ...